• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION ENDOTAK RELIANCE G; IMPLANTABLE LEAD

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION ENDOTAK RELIANCE G; IMPLANTABLE LEAD Back to Search Results
Model Number 0186
Medical Device Problem Code High impedance (1291)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 10/04/2017
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
This investigation will be updated should further pertinent information be provided.
 
Event or Problem Description
It was reported that this right ventricular (rv) lead has been showing high, out of range shock impedances that have been increasing over time.More analysis was recommended but the rv lead remains in service at this point.No adverse patient effects were reported.
 
Additional Manufacturer Narrative
This investigation will be updated should further pertinent information be provided.
 
Event or Problem Description
It was reported that this right ventricular (rv) lead has been showing high, out of range shock impedances that have been increasing over time.More analysis was recommended.At this time the rv lead has been explanted and returned for analysis.No additional adverse patient effects were reported.
 
Additional Manufacturer Narrative
Upon receipt at our post market quality assurance laboratory, a thorough evaluation of the lead was performed.Testing was completed to assess lead electrical performance.Measurements were within normal limits.Microscopic inspections of the terminal pin assembly and the returned part of the lead body found no anomalies.Laboratory testing was unable to reproduce the reported clinical observations and detailed analysis did not reveal any abnormalities.Laboratory analysis did not identify any lead characteristics that would have caused or contributed to the reported clinical observations.This investigation will be updated should further pertinent information be provided.
 
Event or Problem Description
It was reported that this right ventricular (rv) lead has been showing high, out of range shock impedances that have been increasing over time.More analysis was recommended.At this time the rv lead has been explanted and returned for analysis.No additional adverse patient effects were reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ENDOTAK RELIANCE G
Common Device Name
IMPLANTABLE LEAD
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
4100 hamline avenue north
saint paul MN 55112
Manufacturer (Section G)
CPI - DEL CARIBE
guidant puerto rico b. v.
#12, rd. #698
dorado PR 00646
Manufacturer Contact
timothy degroot
4100 hamline avenue north
saint paul, MN 55112
6515826168
MDR Report Key14628230
Report Number2124215-2022-20015
Device Sequence Number6113684
Product Code LWS
UDI-Device Identifier00802526531200
UDI-Public00802526531200
Combination Product (Y/N)Y
Initial Reporter StateCA
Initial Reporter CountryUS
PMA/510(K) Number
P910073/S043
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2008
Device Explanted Year2022
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Health Professional
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup,Followup
Report Date (Section B) 11/11/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Lay User/Patient
Device Expiration Date03/03/2010
Device Model Number0186
Device Catalogue Number0186
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 05/10/2022
Supplement Date Received by Manufacturer09/21/2022
11/08/2022
Initial Report FDA Received Date06/07/2022
Supplement Report FDA Received Date10/12/2022
11/11/2022
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured03/03/2008
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention; Hospitalization;
Patient Age70 YR
Patient SexMale
-
-